Omnicell

$70.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.61 (-2.22%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Omnicell and other stocks, options, ETFs, and crypto commission-free!

About OMCL

Omnicell, Inc. engages in the provision of medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions. It operates through Automation & Analytics and Medication Adherence segments. Read More The Automation & Analytics segment designs, manufactures, and sells medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment develops, manufactures and sells solutions to assist patients in becoming and remaining adherent to their medication regimens. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Employees
2,480
Headquarters
Mountain View, California
Founded
1992
Market Cap
2.96B
Price-Earnings Ratio
62.23
Dividend Yield
0.00
Average Volume
261.76K
High Today
$74.13
Low Today
$70.51
Open Price
$72.20
Volume
358.72K
52 Week High
$92.59
52 Week Low
$56.96

Collections

OMCL News

ReutersAug 7

Edited Transcript of OMCL earnings conference call or presentation 25-Jul-19 8:30pm GMT

7

OMCL Earnings

$0.25
$0.40
$0.55
$0.70
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 24, After Hours

More OMCL News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.